The SYGMA programme of phase 3 trials to evaluate the efficacy and safety of budesonide/formoterol given ‘as needed’ in mild asthma: study protocols for two randomised controlled trials

BACKGROUND: In many patients with mild asthma, the low frequency of symptoms and the episodic nature of exacerbations make adherence to regular maintenance treatment difficult. This often leads to over-reliance on short-acting β(2)-agonist (SABA) reliever medication and under-treatment of the underl...

Descripción completa

Detalles Bibliográficos
Autores principales: O’Byrne, Paul M., FitzGerald, J. Mark, Zhong, Nanshan, Bateman, Eric, Barnes, Peter J., Keen, Christina, Almqvist, Gun, Pemberton, Kristine, Jorup, Carin, Ivanov, Stefan, Reddel, Helen K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5223341/
https://www.ncbi.nlm.nih.gov/pubmed/28069068
http://dx.doi.org/10.1186/s13063-016-1731-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5223341/
https://www.ncbi.nlm.nih.gov/pubmed/28069068
http://dx.doi.org/10.1186/s13063-016-1731-4

Ejemplares similares